مقالات بحثية تمّ التفويض بإتاحتها للجميع - James Yarmolinskyمزيد من المعلومات
الإجماليMRCCancer Research UKNIHRWellcomeNIHWorld Cancer Researh Fund, UKBHFESRCDiabetes UKEuropean CommissionNHMRCCIHRUK Research & InnovationAcademy of FinlandSwedish Research CouncilDoDCPRITSNSFVAARCGenome CanadaDFGVersus Arthritis, UKBBSRCEPSRCZonMwSusan G. KomenFWFCCSNSFCHelmholtzINSERMFORTEKnut and Alice Wallenberg FoundationCSORCNANRGovernment of SpainBMBFKWFGovernment of ItalyAIRC Foundation for Cancer Research in ItalyDamon Runyon Cancer Research FoundationFlorida Department of Health, USAHealth Data Research, UKRoyal Society UK
عدد المقالات البحثية غير المتاحة للجميع في أي موقع: 3
RE: Exploring the cross-cancer effect of circulating proteins and discovering potential intervention targets for 13 site-specific cancers
J Yarmolinsky, I Tzoulaki, MJ Gunter, RC Travis, G Davey Smith, ...
JNCI: Journal of the National Cancer Institute 116 (5), 764-765, 2024
التفويضات: Cancer Research UK, UK Research & Innovation
The effect of circulating proteins and their role in mediating adiposity’s effect on endometrioid and non-endometrioid endometrial cancer risk: Mendelian randomisation and …
SE Wang, VY Tan, J Yarmolinsky, Y Zheng, TA O’Mara, NJ Timpson, ...
التفويضات: National Health and Medical Research Council, Australia, Cancer Research UK …
Promoting erections to improve fertility, sexual activity and wellbeing: Mendelian randomisation study of a drug target for erectile dysfunction
J Yarmolinsky, S Burgess, MRCB Unit
التفويضات: UK Economic and Social Research Council
عدد المقالات البحثية المتاحة للجميع في موقع ما: 60
The MR-Base platform supports systematic causal inference across the human phenome
G Hemani, J Zheng, B Elsworth, KH Wade, V Haberland, D Baird, ...
elife 7, e34408, 2018
التفويضات: Australian Research Council, National Health and Medical Research Council …
Strengthening the reporting of observational studies in epidemiology using Mendelian randomization: the STROBE-MR statement
VW Skrivankova, RC Richmond, BAR Woolf, J Yarmolinsky, NM Davies, ...
Jama 326 (16), 1614-1621, 2021
التفويضات: Swiss National Science Foundation, UK Economic and Social Research Council …
Phenome-wide Mendelian randomization mapping the influence of the plasma proteome on complex diseases
J Zheng, V Haberland, D Baird, V Walker, PC Haycock, MR Hurle, ...
Nature genetics 52 (10), 1122-1131, 2020
التفويضات: British Heart Foundation, Cancer Research UK, Chief Scientist Office …
Causal inference in cancer epidemiology: what is the role of Mendelian randomization?
J Yarmolinsky, KH Wade, RC Richmond, RJ Langdon, CJ Bull, KM Tilling, ...
Cancer Epidemiology, Biomarkers & Prevention 27 (9), 995-1010, 2018
التفويضات: Cancer Research UK, UK Medical Research Council, Wellcome Trust
Circulating selenium and prostate cancer risk: a Mendelian randomization analysis
J Yarmolinsky, C Bonilla, PC Haycock, RJQ Langdon, LA Lotta, ...
JNCI: Journal of the National Cancer Institute 110 (9), 1035-1038, 2018
التفويضات: US National Institutes of Health, Cancer Research UK, UK Medical Research …
STROBE-MR: guidelines for strengthening the reporting of Mendelian randomization studies
GD Smith, NM Davies, N Dimou, M Egger, V Gallo, R Golub, JPT Higgins, ...
PeerJ Preprints, 2019
التفويضات: Swiss National Science Foundation
Association between genetically proxied inhibition of HMG-CoA reductase and epithelial ovarian cancer
J Yarmolinsky, CJ Bull, EE Vincent, J Robinson, A Walther, GD Smith, ...
Jama 323 (7), 646-655, 2020
التفويضات: Cancer Research UK, Diabetes UK, UK Medical Research Council, National …
Circulating inflammatory cytokines and risk of five cancers: a Mendelian randomization analysis
E Bouras, V Karhunen, D Gill, J Huang, PC Haycock, MJ Gunter, ...
BMC medicine 20, 1-15, 2022
التفويضات: US National Institutes of Health, German Research Foundation, Academy of …
Appraising the role of previously reported risk factors in epithelial ovarian cancer risk: a Mendelian randomization analysis
J Yarmolinsky, CL Relton, A Lophatananon, K Muir, U Menon, ...
PLoS medicine 16 (8), e1002893, 2019
التفويضات: US National Institutes of Health, Cancer Research UK, UK Medical Research …
MR-Base: a platform for systematic causal inference across the phenome using billions of genetic associations
G Hemani, J Zheng, KH Wade, C Laurin, B Elsworth, S Burgess, ...
eLife Sciences Publications, Ltd, 2018
التفويضات: Australian Research Council, National Health and Medical Research Council …
Identifying molecular mediators of the relationship between body mass index and endometrial cancer risk: a Mendelian randomization analysis
E Hazelwood, E Sanderson, VY Tan, KS Ruth, TM Frayling, N Dimou, ...
BMC medicine 20 (1), 125, 2022
التفويضات: US National Institutes of Health, National Health and Medical Research …
Genetically proxied therapeutic inhibition of antihypertensive drug targets and risk of common cancers: A mendelian randomization analysis
J Yarmolinsky, V Díez-Obrero, TG Richardson, M Pigeyre, J Sjaarda, ...
PLoS medicine 19 (2), e1003897, 2022
التفويضات: US National Institutes of Health, Cancer Research UK, Diabetes UK, UK …
Strategies to investigate and mitigate collider bias in genetic and Mendelian randomisation studies of disease progression
RE Mitchell, AE Hartley, VM Walker, A Gkatzionis, J Yarmolinsky, JA Bell, ...
PLoS genetics 19 (2), e1010596, 2023
التفويضات: UK Medical Research Council
Investigating the transparency of reporting in two-sample summary data Mendelian randomization studies using the MR-Base platform
B Woolf, N Di Cara, C Moreno-Stokoe, V Skrivankova, K Drax, ...
International Journal of Epidemiology 51 (6), 1943-1956, 2022
التفويضات: Cancer Research UK, UK Economic and Social Research Council, UK Medical …
Genetic and observational evidence supports a causal role of sex hormones on the development of asthma
R Arathimos, R Granell, P Haycock, RC Richmond, J Yarmolinsky, ...
Thorax 74 (7), 633-642, 2019
التفويضات: UK Biotechnology and Biological Sciences Research Council, UK Economic and …
Statins as potential chemoprevention or therapeutic agents in cancer: a model for evaluating repurposed drugs
N Joharatnam-Hogan, L Alexandre, J Yarmolinsky, B Lake, N Capps, ...
Current Oncology Reports 23, 1-13, 2021
التفويضات: Cancer Research UK, UK Medical Research Council, National Institute for …
Association between genetically proxied PCSK9 inhibition and prostate cancer risk: A Mendelian randomisation study
S Fang, J Yarmolinsky, D Gill, CJ Bull, CM Perks, ...
PLoS Medicine 20 (1), e1003988, 2023
التفويضات: Cancer Research UK, UK Medical Research Council, National Institute for …
يتم تحديد معلومات التمويل والنشر من خلال برنامج كمبيوتر تلقائيًا.